List your tool

Head to head · 2026

Abridge vs Regard

Pricing, free plans, ratings, features, pros and cons, side by side. Where one comes out ahead, we mark it.

Abridge

Deployed at 300+ health systems, now backed by a strategic investment from Eli Lilly

4.5Not listed

Visit Abridge (opens Abridge in a new tab)

Regard

Reviews the entire patient chart to surface diagnoses clinicians might otherwise miss

4.1Not listed

Visit Regard (opens Regard in a new tab)

Who comes out ahead

Based only on the facts in our directory. The right pick still depends on the job you need done.

  • Lower starting price

    Not comparable

    Not comparable: Abridge does not list a price

  • Free plan

    Tie

    Neither has one

  • Higher rating

    Abridge

    4.5 against 4.1

  • Same job?

    Yes

    Both are Healthcare AI tools

Side by side

Compared onAbridgeRegard
Our rating4.5Better4.1
Starts atNot listedNot listed
Free planNoNo
CategoryHealthcare AIHealthcare AI
PlansSee pricingSee pricing
Key features
  • Ambient listening that turns patient-clinician conversations into structured notes
  • Deployed at Mayo Clinic, Duke Health, Johns Hopkins, and 300+ health systems
  • #1 Best in KLAS for Ambient AI in Revenue Cycle Management, two years running
  • Expanding beyond documentation into billing and clinical decision support
  • Roughly $830M raised, $5.3B valuation as of its Series E extension
  • Reviews the entire patient chart, not just a single conversation, for missed diagnoses
  • Combines EHR chart data with physician-patient conversation data
  • Surfaces conditions like malnutrition, sepsis risk, and undiagnosed hypertension
  • $61M Series B led by Oak HC/FT, with Cedars-Sinai Health Ventures participating
  • Over $100M raised total as of 2026
Pros
  • Exceptional enterprise validation at some of the most prominent health systems
  • Strong, sustained KLAS recognition specifically for ambient AI quality
  • Expanding scope beyond documentation adds value without switching platforms
  • Full-chart review catches diagnostic gaps a single conversation-based tool would miss
  • Backed by Cedars-Sinai, a health system with direct clinical validation credibility
  • Combines documentation generation with genuine diagnostic-insight surfacing
Cons
  • Enterprise pricing requires a sales conversation, no published self-serve rate
  • Built for large health system deployments, less suited to a solo practitioner
  • Broadening scope into billing and trial screening adds platform complexity to evaluate
  • Enterprise quote-based pricing requires a sales conversation, no published rates
  • Requires deep EHR integration across a health system to deliver full value
  • Smaller company scale than the largest ambient documentation competitors
CompanyAbridge, founded 2018Regard, founded 2016

Prices come from each vendor's pricing page, last checked 20260715. Check the vendor before you buy.

FAQ

Questions people ask

Is Abridge better than Regard?

In our reviews Abridge scores 4.5 and Regard scores 4.1. The better pick depends on the job. Abridge: Deployed at 300+ health systems, now backed by a strategic investment from Eli Lilly. Regard: Reviews the entire patient chart to surface diagnoses clinicians might otherwise miss.

Which is cheaper, Abridge or Regard?

Abridge: see pricing. Regard: see pricing.

Do Abridge and Regard have free plans?

Neither lists a free plan.

More comparisons